According to Allergy UK, an estimated 21 million of people in the UK suffer from at least one allergy, 8 million people live with skin disease in the UK (according to the British skin foundation).
Exposure of gut to pathogens, toxins and allergens may result in development of allergic reactions.
For this reason as part of a comprehensive treatment of allergies, associated with gastrointestinal disorders, it is proven to be beneficial to protect the gastrointestinal tract and normalise the intestinal flora.
Working like a “clever sponge” in the gut Enterosgel is developed to adsorb bacterial toxins and other harmful medium-weight molecular substances, including allergens. It has a protective effect on the intestinal mucous membrane and a positive influence on the intestinal flora. ENTEROSGEL is an effective adjuvant in treatment of allergies with gastrointestinal symptoms in children and adults.